These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
519 related items for PubMed ID: 15593087
1. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S. Cancer; 2005 Jan 15; 103(2):307-12. PubMed ID: 15593087 [Abstract] [Full Text] [Related]
4. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma. Choi GH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Lee WJ, Han KH, Chon CY, Kim BR. J Gastroenterol Hepatol; 2009 Mar 15; 24(3):391-8. PubMed ID: 19032452 [Abstract] [Full Text] [Related]
6. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Cancer; 2005 Jan 15; 103(2):299-306. PubMed ID: 15578688 [Abstract] [Full Text] [Related]
7. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. Shimozawa N, Hanazaki K. J Am Coll Surg; 2004 Mar 15; 198(3):356-65. PubMed ID: 14992736 [Abstract] [Full Text] [Related]
8. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Ann Surg Oncol; 2008 May 15; 15(5):1375-82. PubMed ID: 18324443 [Abstract] [Full Text] [Related]
13. [Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma]. Wu FS, Zhao WH, Liang TB, Ren GP, Ma ZM, Teng LS. Zhonghua Wai Ke Za Zhi; 2005 May 01; 43(9):579-83. PubMed ID: 15938929 [Abstract] [Full Text] [Related]
14. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S. Ann Surg; 2006 Sep 01; 244(3):451-63. PubMed ID: 16926571 [Abstract] [Full Text] [Related]
15. Prognosis of early hepatocellular carcinoma after hepatic resection. Maeda T, Shimada M, Harimoto N, Tsujita E, Aishima S, Tanaka S, Shirabe K, Maehara Y. Hepatogastroenterology; 2008 Sep 01; 55(85):1428-32. PubMed ID: 18795705 [Abstract] [Full Text] [Related]
17. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma]. Zhang GQ, Ge L, Ding W, Li HJ. Ai Zheng; 2008 Dec 01; 27(12):1297-301. PubMed ID: 19079997 [Abstract] [Full Text] [Related]
20. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Cancer; 2013 Jan 01; 119(1):126-35. PubMed ID: 22736338 [Abstract] [Full Text] [Related] Page: [Next] [New Search]